The prognostic significance of prior heart failure in acute coronary syndromes has not been well studied. Accordingly, we evaluated the baseline characteristics, management patterns and clinical outcomes in patients with acute coronary syndromes who had prior heart failure.
Methods and results:
The study population consisted of acute coronary syndrome patients in the Global Registry of Acute Coronary Events, expanded Global Registry of Acute Coronary Events and Canadian Registry of Acute Coronary Events between 1999 and 2008. Of the 13,937 eligible patients (mean age 66±13 years, 33% female and 28.3% with ST-elevation myocardial infarction), 1498 (10.7%) patients had a history of heart failure. Those with prior heart failure tended to be older, female and had lower systolic blood pressure, higher Killip class and creatinine on presentation. Prior heart failure was also associated with significantly worse left ventricular systolic function and lower rates of cardiac catheterization and coronary revascularization. The group with previous heart failure had significantly higher rates of acute decompensated heart failure, cardiogenic shock, myocardial (re)infarction and mortality in hospital. In multivariable analysis, prior heart failure remained an independent predictor of in-hospital mortality (odds ratio 1.48, 95% confidence interval 1.08–2.03, p=0.015).
Conclusions:
Prior heart failure was associated with high risk features on presentation and adverse outcomes including higher adjusted in-hospital mortality in acute coronary syndrome patients. However, acute coronary syndrome patients with prior heart failure were less likely to receive evidence-based therapies, suggesting potential opportunities to target more intensive treatment to improve their outcome.
GheorghiadeMBonowRO. Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation1998; 97: 282–289.
2.
BahitMCLopesRDClareRM. Heart failure complicating non – ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes. J Am Coll Cardio HF2013; 1: 223–229.
3.
StegPGDabbousOHFeldmanLJ. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observation from the Global Registry of Acute Coronary Events (GRACE). Circulation2004; 109: 494–499.
4.
WuAHParsonsLEveryNR. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the second national Registry of Myocardial Infarction ( NRMI-2 ). J Am Coll Cardiol. 2002; 40: 1389–1394.
5.
KhotUNJiaGMoliternoD. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA2003; 290: 2174–2181.
6.
ShahRVHolmesDAndersonM. Risk of heart failure complication during a contemporary population: insights from the national cardiovascular data ACTION registry. Circ Hear Fail2012; 5: 693–702.
7.
The GRACE Investigators. Rationale and design of the GRACE ( Global Registry of Acute Coronary Events ) project: A multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J2001; 141: 190–199.
8.
GoodmanSGHuangWYanAT. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J2009; 158: 193–201.
9.
GrangerCBGoldbergRJDabbousO. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med2003; 163: 2345–2353.
10.
CookNRRidkePM. The use and magnitude of reclassification measures for individual predictors of global cardiovascular risk. Ann Intern Med2009; 150: 795–802.
11.
DiepenSVChenAYWangTY. Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non – ST-segment elevation myocardial infarction. Am Heart J2014; 167: 267–273.
12.
SpencerFAMeyerTEGoreJM. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: The National Registry of Myocardial Infarction. Circulation2002; 105: 2605–2610.
13.
RoeMTChenAYRibaAL. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol2006; 97: 1707–1712.
14.
StegPGKernerAVan De WerfF. Impact of in-hospital revascularization on survival in patients with non – ST-elevation acute coronary syndrome and congestive heart failure. Circulation2008; 118: 1163–1171.
15.
AbrahamssonPDobsonJGrangerCB. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. Eur Heart J2009 ;30: 338–345.
16.
RanasingheINaoumCAliprandi-CostaB. Management and outcomes following an acute coronary event in patients with chronic heart failure 1999–2007. Eur J Hear Fail2012; 14: 464–472.
17.
EagleKALimMJDabbousOH. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA2004; 291: 2727–2733.
18.
SanchisJNúñezJBodíV. Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome. Mayo Clin Proc2011; 86: 291–296.
19.
IakobishviliZFeinbergMSDanicekV. Prior heart failure among patients with acute coronary syndromes is associated with a higher incidence of in-hospital heart failure. Acute Card Care2006; 8: 143–147.
20.
FoxKAStegPGEagleKA. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA2007; 297: 1892–1900.
21.
DargieHJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet2001; 357: 1385–1390.
22.
PackerMCoatsAFowlerMB. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med2001; 344: 1651–1658.
23.
The Merit-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet1999; 353: 2001–2007.
24.
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet1993; 342: 821–828.
25.
Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet1994; 343: 1115–1122.
26.
ChenZMPanHCChenYP. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet2005; 366: 1622–1632.
27.
PfefferMASwedbergKGrangerCB. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet2003; 362: 759–766.
28.
BhattDLRoeMTPetersonED. Utilization of early invasive management strategies for high-risk patients: results from the CRUSADE quality improvement initiative. JAMA2004; 292: 2096–2104.
29.
FoxKPoole-WilsonPHendersonR. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet2002; 360: 743–751.
30.
MehtaSRGrangerCBBodenWE. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med2009; 360: 2165–2175.
31.
KatritsisDGSiontisGCMKastratiA. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J2011; 32: 32–40.
32.
StenestrandUWallentinL. Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study. Lancet2002; 359: 1805–1811.
33.
HochmanJSSleeperLAWebbJG. Early revascularization and long-term survivcal in cardiogenic shock complicating acute myocardial infarction. JAMA2014; 295: 2511–2515.
34.
GoelKPintoDSGibsonCM. Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: A systematic review. Am Heart J2013; 165: 451–467.
35.
HammCWBassandJPAgewallS. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio. Eur Heart J2011; 32: 2999–3054.
36.
CheitlinMDArmstrongWFAurigemmaGP. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. J Am Soc Echocardiogr2003; 16: 1091–1110.
37.
AndersonJLAdamsCDAntmanEM. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association. J Am Coll Cardiol2013; 61: 179–347.
38.
JedrzkiewiczSGoodmanSGYanRT. Evaluation of left ventricular ejection fraction in non-ST-segment elevation acute coronary syndromes and its relationship to treatment. Am Heart J2010; 159: 605–611.
39.
StevensonLWPerloffJK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA1989; 261: 884–888.
